NIAID Now

Filter NIAID Now Blog by year:
2026 | 2025 | 2024

1 Results

COVID-19 Respiratory Treatment Effective in Encephalitis Study

Antiviral drug molnupiravir, a COVID-19 treatment, was effective when tested in mice in preventing viruses that cause brain swelling, particularly in children. The scientists studied LACV because it broadly represents several RNA viruses that cause disease in the CNS, including Jamestown Canyon and Cache Valley viruses – which also were part of the study – and rabies, polio, West Nile, Nipah and several other viruses not part of the study.

Contact

Contact the NIAID Media Team.
301-402-1663

niaidnews@niaid.nih.gov